Pharmaceuticals & Biotech Canadian Companies

RAMM Pharma

Market Cap: CA$1.8m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

TILT Holdings

Market Cap: CA$2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

Appili Therapeutics

Market Cap: CA$2.4m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

Algernon Pharmaceuticals

Market Cap: CA$2.5m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Psyence Group

Market Cap: CA$2.6m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

Restart Life Sciences

Market Cap: CA$2.9m

Through its subsidiaries, operates as a biotechnology company worldwide.

THC Biomed Intl

Market Cap: CA$3.3m

Produces and sells medical and recreational cannabis in Canada.

MindBio Therapeutics

Market Cap: CA$3.4m

Operates as a clinical stage drug development company in Australasia.

Neural Therapeutics

Market Cap: CA$4.2m

A drug discovery company, focuses on plant-based active substances.

Aptose Biosciences

Market Cap: CA$4.3m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

XORTX Therapeutics

Market Cap: CA$5.8m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Ayurcann Holdings

Market Cap: CA$5.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

CanadaBis Capital

Market Cap: CA$6.2m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Core One Labs

Market Cap: CA$6.8m

Operates as a psychedelic research and development company.

Quest PharmaTech

Market Cap: CA$6.8m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

Herbal Dispatch

Market Cap: CA$7.0m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Mountain Valley MD Holdings

Market Cap: CA$7.0m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Kane Biotech

Market Cap: CA$7.1m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Delivra Health Brands

Market Cap: CA$7.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Telo Genomics

Market Cap: CA$7.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

PharmaCielo

Market Cap: CA$8.5m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

Revive Therapeutics

Market Cap: CA$8.6m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Crescita Therapeutics

Market Cap: CA$8.7m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

BioVaxys Technology

Market Cap: CA$8.8m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.